Showing results (231-240 of 501) with videos related to
Sort By:
Pageof 51
BJU International|August 4, 2015
Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancerVinayak Muralidhar, Brandon A Mahal, Michelle D Nezolosky, et al.European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.European Urology Focus|July 28, 2023
Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical ProstatectomyAli Sabbagh, Derya Tilki, Jean Feng, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.Virchows Archiv : an International Journal of Pathology|December 16, 2014
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinomaJoshua I Warrick, Daniel H Hovelson, Anmol Amin, et al.Urologic Oncology|May 4, 2016
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomyMichael A Kozminski, Scott Tomlins, Adam Cole, et al.Cancer Research|December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH BiosynthesisDaniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate CancerVinayak Muralidhar, Paul J Catalano, Gally Reznor, et al.Nature|June 28, 2019
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancerAbhijit Parolia, Marcin Cieslik, Shih-Chun Chu, et al.Pageof 51